Connor, Clark & Lunn Investment Management (CC&L)
IMDX

Connor, Clark & Lunn Investment Management (CC&L)’s Insight Molecular Diagnostics Inc. Common Stock IMDX Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio IMDX Stock Details IMDX Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-556
Closed -$40K – 1166
2021
Q3 		$40K Sell
556
-105
-16% -$7.55K ﹤0.01% 1011
2021
Q2 		$76K Buy
+661
New +$76K ﹤0.01% 949